A cooperative clinical study of photodynamic therapy (PDT) for superficial esophageal carcinoma was conducted at 6 medical institution. PHE (2mg/kg) with high tumor affinity was used as the oncotropic compound. The light source was a pulse wave YAG-OPO laser with high penetration into the tissue. Irradiation was performed at an energy density of 60-180J/cm 2 48-72h after PHE administration. Eight lesions in 6 patients were treated. All were type 0-II superficial carcinomas. The depth of invasion was EP-MM for 6 lesions and SM for 2 lesions. A complete response (CR) was achieved in all patients after one session of PDT. Five adverse events, including anemia and fever, were reported by 4 patients, but all were WHO grade 2 or lower and transient. PDT using PHE and YAG-OPO laser was therefore considered effective as a curative therapy for superficial esophageal carcinoma.
INTRODUCTION
Photodynamic therapy (PDT) is performed by applying laser as excitation light 48-72h after intravenous injection of a photosensitive compound to destroy tumors selectively using the difference in concentration between the tumor and normal tissue. Hayata et al. [1] [2] and Mimura et al. [3] achieved a complete response with PDT for superficial esophageal carcinoma. These studies used a continuous-wave Argon-dye laser. In 1990, an Excimer-dye pulse laser was developed. Pulse lasers provide superior penetration of light into tissue and produce the same results using less energy than continuous lasers [4, 5] . In a phase III clinical study by the authors, PHE (porfimer sodium) and Excimerdye laser were found to be effective in the treatment of superficial esophageal carcinoma [6] Two lesions showed SM invasion and the others were M carcinomas of EP-MM. Two patients had double lesions, which were considered to be two separate lesions and were treated separately with PDT.
MATERIALS AND METHODS

Participating Institution and Study Period
The present study was conducted at 6 institutions on patients enrolled between June 1995 and December 1996.
Subjects
The subjects enrolled in the present study were patients with superficial esophageal carcinoma who met the following criteria. (1) [7] . But patients in whom biopsies remained carcinoma-negative for 4 weeks or longer were considered complete responders.
Assessment of Safety
Safety was assessed using the descriptions of side effects in the criteria for the assessment of the efficacy of chemotherapy for solid cancers. PDT has been reported to be a highly effective treatment for esophageal carcinoma that is capable of curing carcinomas up to the SM stage [8] . However, SM esophageal carcinomas are frequently associated with lympho-vascular involvement and lymph node metastasis [9] . M carcinomas of EP-MM should therefore be treated using local therapy such as PDT. Although endoscopic mucosectomy is becoming the standard treatment for these M carcinomas, PDT has several advantages in that it is simpler to perform than mucosectomy and can be used in patients prone to hemorrhage or with carcinoma complicated by esophageal varices. Another great advantage of PDT is that it is aimed at inoperable cases and is therefore applicable to SM carcinomas.
The local CR rate of 100% obtained in the present study is higher than the efficacy rates reported previously [2, 3, 8] and is superior to the efficacy of pulse-wave Excimer-dye laser [6, 10] .
The laser used in the present study is expected to be highly useful as assessment of safety found no serious side effects in patients with complicating illness.
It was concluded from these results that PDT using the YAG-OPO pulse-wave laser is an effective local therapy.
